TESAMORELIN

TESAMORELIN was reported 1692 times

TESAMORELIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT JOINT NEOPLASM 1 0.0625
1 VAGINAL PH ABNORMAL 1 0.0256
2 NOSOPHOBIA 1 0.0233
3 BENIGN NEOPLASM OF PROSTATE 1 0.0227
4 PRODUCT PREPARATION ISSUE 122 0.0186
5 PRECANCEROUS LESION OF DIGESTIVE TRACT 2 0.0177
6 INSULIN-LIKE GROWTH FACTOR ABNORMAL 2 0.0177
7 ABDOMINAL FAT APRON 2 0.0171
8 FOREIGN BODY IN SKIN OR SUBCUTANEOUS TISSUE 1 0.0145
9 RENAL SCAN ABNORMAL 1 0.0141
10 WAIST CIRCUMFERENCE INCREASED 14 0.0135
11 LIPOSUCTION 2 0.0131
12 FAT REDISTRIBUTION 3 0.0129
13 T-LYMPHOCYTE COUNT ABNORMAL 1 0.0122
14 INJECTION SITE DEFORMATION 1 0.0112
15 ADMINISTRATION SITE INDURATION 1 0.0111
16 LEFT ATRIAL APPENDAGE CLOSURE IMPLANT 1 0.0090
17 SEBACEOUS CARCINOMA 1 0.0087
18 OPTIC DISC OEDEMA 1 0.0086
19 PROSTATIC MASS 1 0.0085
20 BILIRUBIN URINE PRESENT 1 0.0084
21 BLOOD GROWTH HORMONE ABNORMAL 1 0.0082
22 INCARCERATED INGUINAL HERNIA 1 0.0082
23 DENTAL CYST 1 0.0081
24 INJECTION SITE CALCIFICATION 1 0.0080
25 INADVERTENT INJECTION AIR BUBBLE 1 0.0079
26 RHINOPLASTY 1 0.0076
27 PH BODY FLUID ABNORMAL 1 0.0072
28 OROPHARYNGEAL SQUAMOUS CELL CARCINOMA 1 0.0069
29 SKIN LAXITY 3 0.0068
30 FACIAL OPERATION 1 0.0062
31 HAND-EYE COORDINATION IMPAIRED 1 0.0059
32 INSULIN-LIKE GROWTH FACTOR INCREASED 8 0.0056
33 T-LYMPHOCYTE COUNT INCREASED 1 0.0054
34 ADMINISTRATION SITE DISCOMFORT 1 0.0053
35 VENOUS OPERATION 1 0.0051
36 FAT TISSUE DECREASED 2 0.0051
37 MALIGNANT MELANOMA STAGE 0 1 0.0048
38 EXPOSURE TO FUNGUS 1 0.0047
39 SARCOPENIA 2 0.0046
40 INJECTION SITE PARAESTHESIA 7 0.0046
41 NEEDLE FATIGUE 2 0.0044
42 INCREASED NEED FOR SLEEP 1 0.0043
43 GRANULOMATOUS DERMATITIS 1 0.0041
44 FACIAL WASTING 1 0.0037
45 PRODUCT IMPURITY 1 0.0036
46 MONKEYPOX 1 0.0036
47 BLOOD GROWTH HORMONE INCREASED 2 0.0036
48 MALIGNANT NEOPLASM OF EYE 1 0.0035
49 INJECTION SITE CYST 1 0.0034
50 PRODUCT RECONSTITUTION QUALITY ISSUE 3 0.0034
51 SEASONAL AFFECTIVE DISORDER 1 0.0032
52 PHARYNGEAL OPERATION 1 0.0031
53 INJECTION SITE HYPERTROPHY 1 0.0031
54 BLOOD TRIGLYCERIDES DECREASED 1 0.0030
55 LACK OF INJECTION SITE ROTATION 5 0.0029
56 MUSCLE HYPERTROPHY 1 0.0028
57 SALIVARY GLAND CALCULUS 1 0.0027
58 LID SULCUS DEEPENED 1 0.0027
59 SKIN DISCHARGE 1 0.0026
60 PHYSICAL EXAMINATION ABNORMAL 1 0.0026
61 ADRENAL GLAND CANCER 1 0.0026
62 ARACHNOID CYST 1 0.0025
63 INCISION SITE IMPAIRED HEALING 1 0.0025
64 DRUG WITHDRAWAL HEADACHE 1 0.0024
65 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
66 MULTIPLE USE OF SINGLE-USE PRODUCT 13 0.0023
67 HIP DEFORMITY 1 0.0023
68 ACROCHORDON 3 0.0023
69 MUSCLE ENZYME INCREASED 1 0.0023
70 ENLARGED UVULA 1 0.0022
71 HEPATIC ENZYME DECREASED 1 0.0022
72 INJECTION SITE SCAR 6 0.0021
73 DRUG ADMINISTERED IN WRONG DEVICE 2 0.0020
74 ORBITAL OEDEMA 1 0.0020
75 INSULIN-LIKE GROWTH FACTOR DECREASED 1 0.0019
76 BLOOD INSULIN INCREASED 1 0.0018
77 PRODUCT DOSE OMISSION IN ERROR 51 0.0018
78 OESOPHAGEAL FOOD IMPACTION 1 0.0018
79 SUSPECTED PRODUCT TAMPERING 1 0.0018
80 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 1 0.0018
81 BLOOD OESTROGEN INCREASED 1 0.0017
82 DRUG EFFECT LESS THAN EXPECTED 25 0.0017
83 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
84 EMERGENCY CARE 5 0.0016
85 BLOOD CHOLESTEROL DECREASED 3 0.0016
86 PRODUCT ADMINISTRATION ERROR 31 0.0015
87 WRONG DEVICE USED 1 0.0015
88 ABDOMINAL MASS 4 0.0015
89 PNEUMOTHORAX SPONTANEOUS 1 0.0015
90 INJECTION SITE NODULE 16 0.0015
91 LIPODYSTROPHY ACQUIRED 3 0.0014
92 INTENTIONAL DOSE OMISSION 40 0.0014
93 FAT TISSUE INCREASED 2 0.0014
94 OBSTRUCTIVE PANCREATITIS 1 0.0013
95 DEBRIDEMENT 1 0.0013
96 ORAL MUCOSAL ERYTHEMA 2 0.0013
97 INJECTION SITE MASS 46 0.0012
98 INJECTION SITE BRUISING 99 0.0012
99 INJECTION SITE PRURITUS 83 0.0012
100 PARATHYROID DISORDER 1 0.0012
101 VACCINATION COMPLICATION 1 0.0012
102 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 86 0.0012
103 ADRENAL MASS 1 0.0012
104 ENZYME LEVEL INCREASED 1 0.0012
105 LIP PRURITUS 1 0.0012
106 HERNIA REPAIR 3 0.0012
107 CARPAL TUNNEL SYNDROME 16 0.0011
108 INJECTION SITE DISCOMFORT 12 0.0011
109 ACCIDENTAL UNDERDOSE 16 0.0011
110 ABDOMINAL RIGIDITY 3 0.0011
111 INJECTION SITE SCAB 1 0.0010
112 BLADDER CATHETERISATION 1 0.0010
113 ANAL CANCER 1 0.0010
114 APPLICATION SITE BRUISE 1 0.0010
115 PRODUCT PREPARATION ERROR 21 0.0010
116 ENERGY INCREASED 6 0.0010
117 PRODUCT DOSE OMISSION ISSUE 297 0.0010
118 ACQUIRED HAEMOPHILIA 1 0.0010
119 THYROID HORMONES INCREASED 1 0.0010
120 INNER EAR DISORDER 1 0.0009
121 NAIL GROWTH ABNORMAL 1 0.0009
122 METABOLIC SURGERY 1 0.0009
123 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
124 ORAL PRURITUS 2 0.0009
125 PALMAR ERYTHEMA 1 0.0009
126 DISTRACTIBILITY 1 0.0009
127 PAROTITIS 1 0.0009
128 EPIDIDYMITIS 1 0.0009
129 APPENDICECTOMY 3 0.0008
130 CARDIAC DEATH 1 0.0008
131 INCORRECT DOSAGE ADMINISTERED 4 0.0008
132 SPINAL OPERATION 10 0.0008
133 HELICOBACTER GASTRITIS 1 0.0008
134 INJECTION SITE DISCOLOURATION 10 0.0008
135 HYPERAESTHESIA TEETH 1 0.0008
136 GLUCOSE URINE PRESENT 1 0.0008
137 OBSTRUCTION GASTRIC 1 0.0008
138 DRUG TITRATION ERROR 2 0.0008
139 INJECTION SITE INDURATION 10 0.0008
140 SKIN ODOUR ABNORMAL 3 0.0008
141 HIRSUTISM 1 0.0008
142 TRIGGER FINGER 3 0.0007
143 CLUSTER HEADACHE 1 0.0007
144 INTESTINAL MASS 1 0.0007
145 CORNEAL ABRASION 1 0.0007
146 INCORRECT DOSE ADMINISTERED 164 0.0007
147 GLUTEN SENSITIVITY 1 0.0007
148 VASCULAR GRAFT 2 0.0007
149 NOROVIRUS INFECTION 1 0.0007
150 INJECTION SITE URTICARIA 17 0.0007
151 VASCULAR INJURY 1 0.0007
152 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
153 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
154 AXILLARY PAIN 1 0.0007
155 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
156 PRODUCT DISTRIBUTION ISSUE 6 0.0006
157 BACTERIAL VAGINOSIS 1 0.0006
158 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
159 PAPILLOMA VIRAL INFECTION 1 0.0006
160 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
161 TREATMENT NONCOMPLIANCE 33 0.0006
162 MEDICAL PROCEDURE 1 0.0006
163 GASTRIC DILATATION 1 0.0006
164 FOOD AVERSION 1 0.0006
165 GLIOBLASTOMA 1 0.0006
166 MILIARIA 1 0.0006
167 HAIR GROWTH ABNORMAL 4 0.0006
168 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
169 WEIGHT FLUCTUATION 6 0.0006
170 ABNORMAL WEIGHT GAIN 7 0.0006
171 INDURATION 1 0.0006
172 PRODUCT SUPPLY ISSUE 4 0.0006
173 MUSCLE TIGHTNESS 9 0.0006
174 HYPERTRICHOSIS 1 0.0005
175 TUNNEL VISION 1 0.0005
176 INJECTION SITE PAIN 160 0.0005
177 HYPERPARATHYROIDISM 1 0.0005
178 SPINAL STENOSIS 2 0.0005
179 SKIN INDURATION 1 0.0005
180 INSULIN RESISTANCE 1 0.0005
181 INJECTION SITE IRRITATION 6 0.0005
182 BLOOD TESTOSTERONE INCREASED 1 0.0005
183 MUSCULOSKELETAL DISCOMFORT 8 0.0005
184 INJECTION SITE RASH 14 0.0005
185 TEMPERATURE REGULATION DISORDER 1 0.0004
186 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
187 CHRONIC GASTRITIS 1 0.0004
188 WEIGHT INCREASED 99 0.0004
189 PERIARTHRITIS 1 0.0004
190 BLOOD TESTOSTERONE DECREASED 3 0.0004
191 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 8 0.0004
192 ORAL SURGERY 1 0.0004
193 SKIN TIGHTNESS 2 0.0004
194 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
195 JOINT STIFFNESS 11 0.0004
196 URINE FLOW DECREASED 1 0.0004
197 HAEMATOLOGICAL INFECTION 1 0.0004
198 PERIPHERAL SWELLING 62 0.0004
199 INJECTION SITE ABSCESS 1 0.0004
200 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
201 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
202 ANGLE CLOSURE GLAUCOMA 1 0.0004
203 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 79 0.0004
204 MEAN CELL VOLUME INCREASED 1 0.0004
205 LIPOMA 1 0.0004
206 URINE OUTPUT INCREASED 1 0.0004
207 FOOD CRAVING 2 0.0004
208 INJECTION SITE HAEMORRHAGE 30 0.0004
209 ABDOMINAL DISTENSION 39 0.0004
210 FLUID RETENTION 19 0.0004
211 INJECTION SITE DISCHARGE 2 0.0004
212 SKIN WRINKLING 1 0.0004
213 RED BLOOD CELL COUNT INCREASED 1 0.0004
214 PROSTATIC DISORDER 2 0.0004
215 EOSINOPHILIC OESOPHAGITIS 1 0.0004
216 THERAPEUTIC RESPONSE DELAYED 1 0.0004
217 ANGIOPATHY 2 0.0004
218 SKIN HYPERTROPHY 1 0.0004
219 NEUTROPHIL COUNT ABNORMAL 1 0.0004
220 FIBULA FRACTURE 1 0.0003
221 VOMITING PROJECTILE 1 0.0003
222 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
223 IRITIS 1 0.0003
224 RECTAL CANCER 1 0.0003
225 MENISCUS INJURY 2 0.0003
226 FLANK PAIN 3 0.0003
227 BLOOD BLISTER 1 0.0003
228 PRODUCT STORAGE ERROR 28 0.0003
229 INJECTION SITE HYPERSENSITIVITY 1 0.0003
230 PRODUCT USE COMPLAINT 5 0.0003
231 ABDOMINAL ADHESIONS 1 0.0003
232 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
233 MYALGIA 53 0.0003
234 POLYP 2 0.0003
235 KNEE OPERATION 3 0.0003
236 INJECTION SITE INFECTION 1 0.0003
237 NEAR DEATH EXPERIENCE 1 0.0003
238 SKIN INJURY 1 0.0003
239 SKIN MASS 2 0.0003
240 FREQUENT BOWEL MOVEMENTS 8 0.0003
241 ABNORMAL LOSS OF WEIGHT 2 0.0003
242 LEFT VENTRICULAR FAILURE 1 0.0003
243 LARGE INTESTINE POLYP 2 0.0003
244 MICTURITION DISORDER 1 0.0003
245 MASS 4 0.0003
246 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
247 SCRATCH 3 0.0003
248 PROSTATE CANCER STAGE IV 1 0.0003
249 PRODUCT CONTAMINATION 1 0.0003
250 RENAL TRANSPLANT 1 0.0003
251 TONGUE DISORDER 2 0.0003
252 BACK INJURY 3 0.0003
253 SPONDYLITIS 1 0.0003
254 ACCIDENTAL OVERDOSE 10 0.0003
255 ARTHRALGIA 113 0.0003
256 HYPOAESTHESIA 40 0.0003
257 THROAT CLEARING 1 0.0003
258 INJECTION SITE ERYTHEMA 33 0.0003
259 PRODUCT STORAGE ISSUE 1 0.0003
260 PRODUCT AVAILABILITY ISSUE 6 0.0003
261 TROPONIN INCREASED 2 0.0003
262 NEPHROLITHIASIS 12 0.0003
263 GASTRIC INFECTION 1 0.0003
264 THYROID MASS 1 0.0003
265 LIMB DISCOMFORT 8 0.0003
266 CONCUSSION 2 0.0003
267 REHABILITATION THERAPY 1 0.0003
268 PANIC DISORDER 1 0.0003
269 VIRAL LOAD INCREASED 1 0.0003
270 PAIN IN EXTREMITY 75 0.0003
271 PROSTATOMEGALY 1 0.0003
272 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
273 FURUNCLE 2 0.0003
274 SKIN PAPILLOMA 1 0.0002
275 CONTUSION 24 0.0002
276 GALLBLADDER OPERATION 1 0.0002
277 SELF-MEDICATION 1 0.0002
278 APPLICATION SITE EXFOLIATION 1 0.0002
279 THYROID FUNCTION TEST ABNORMAL 1 0.0002
280 THERAPY INTERRUPTED 17 0.0002
281 MUSCLE ATROPHY 3 0.0002
282 MUSCLE FATIGUE 1 0.0002
283 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
284 PURULENT DISCHARGE 1 0.0002
285 ALCOHOLISM 1 0.0002
286 PRODUCT CONTAINER ISSUE 2 0.0002
287 ABNORMAL SENSATION IN EYE 1 0.0002
288 INJECTION SITE REACTION 16 0.0002
289 SKIN CANCER 5 0.0002
290 TOOTH INJURY 1 0.0002
291 MELANOCYTIC NAEVUS 1 0.0002
292 ABDOMINAL ABSCESS 1 0.0002
293 VULVOVAGINAL DISCOMFORT 1 0.0002
294 RHINITIS ALLERGIC 1 0.0002
295 BRAIN NEOPLASM MALIGNANT 1 0.0002
296 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
297 URINE ABNORMALITY 1 0.0002
298 ABDOMINAL HERNIA 1 0.0002
299 EXOSTOSIS 2 0.0002
300 LUMBAR VERTEBRAL FRACTURE 1 0.0002
301 MUSCULOSKELETAL STIFFNESS 19 0.0002
302 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
303 INTERCEPTED MEDICATION ERROR 1 0.0002
304 POLLAKIURIA 9 0.0002
305 RENAL FUNCTION TEST ABNORMAL 1 0.0002
306 MIDDLE INSOMNIA 4 0.0002
307 UMBILICAL HERNIA 1 0.0002
308 SKIN REACTION 3 0.0002
309 FEELING HOT 13 0.0002
310 SARCOIDOSIS 1 0.0002
311 PRODUCT PACKAGING ISSUE 2 0.0002
312 INCREASED APPETITE 4 0.0002
313 TUMOUR MARKER INCREASED 1 0.0002
314 PARAESTHESIA ORAL 3 0.0002
315 HERNIA 4 0.0002
316 PRODUCT USE IN UNAPPROVED INDICATION 51 0.0002
317 BLADDER DISORDER 2 0.0002
318 ABDOMINAL TENDERNESS 1 0.0002
319 COLON CANCER 3 0.0002
320 ANEURYSM 1 0.0002
321 CORONARY ARTERY STENOSIS 1 0.0002
322 PARAESTHESIA 31 0.0002
323 TOE AMPUTATION 1 0.0002
324 DRY THROAT 2 0.0002
325 WEIGHT LOSS POOR 1 0.0002
326 INITIAL INSOMNIA 2 0.0002
327 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
328 ANKLE FRACTURE 3 0.0002
329 JOINT SWELLING 23 0.0002
330 ADVERSE DRUG REACTION 17 0.0002
331 PNEUMOTHORAX 3 0.0002
332 SCIATICA 3 0.0002
333 ANAL FISSURE 1 0.0002
334 OVERWEIGHT 1 0.0002
335 BLOOD GLUCOSE INCREASED 35 0.0002
336 HIP SURGERY 1 0.0002
337 PRODUCT DISPENSING ERROR 4 0.0002
338 HYDROCEPHALUS 1 0.0002
339 BLOOD GLUCOSE FLUCTUATION 2 0.0002
340 NONSPECIFIC REACTION 1 0.0002
341 SWELLING 17 0.0002
342 DEAFNESS UNILATERAL 1 0.0002
343 EXPIRED PRODUCT ADMINISTERED 6 0.0002
344 NEUROPATHY PERIPHERAL 17 0.0002
345 CHOLECYSTITIS ACUTE 1 0.0002
346 HOSPITALISATION 27 0.0002
347 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
348 HYPERTONIA 1 0.0002
349 HERPES VIRUS INFECTION 1 0.0002
350 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
351 METABOLIC DISORDER 1 0.0002
352 BACK PAIN 40 0.0002
353 SURGERY 10 0.0002
354 DIABETES MELLITUS 13 0.0002
355 URINE ODOUR ABNORMAL 1 0.0002
356 CATARACT OPERATION 1 0.0002
357 PRODUCT PRESCRIBING ERROR 4 0.0002
358 THIRST 3 0.0002
359 ACCIDENT 2 0.0002
360 SYMPTOM RECURRENCE 1 0.0002
361 GANGRENE 1 0.0002
362 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
363 LOCALISED INFECTION 4 0.0002
364 PELVIC PAIN 3 0.0002
365 BURSITIS 2 0.0002
366 NOCTURIA 2 0.0002
367 DERMATITIS ACNEIFORM 1 0.0002
368 VULVOVAGINAL BURNING SENSATION 1 0.0002
369 BLOOD GLUCOSE ABNORMAL 3 0.0002
370 PIGMENTATION DISORDER 1 0.0002
371 SECRETION DISCHARGE 2 0.0002
372 SWELLING OF EYELID 1 0.0002
373 HEAD INJURY 5 0.0002
374 THERAPEUTIC RESPONSE CHANGED 1 0.0002
375 URTICARIA 26 0.0002
376 CARDIAC FLUTTER 1 0.0002
377 TENDON DISORDER 1 0.0002
378 NODULE 2 0.0002
379 DEPRESSED MOOD 8 0.0002
380 NEOPLASM MALIGNANT 10 0.0001
381 DRY MOUTH 12 0.0001
382 THROAT TIGHTNESS 4 0.0001
383 ANGER 5 0.0001
384 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
385 MOOD ALTERED 4 0.0001
386 NEPHROTIC SYNDROME 1 0.0001
387 NIGHTMARE 5 0.0001
388 HUNGER 2 0.0001
389 INJECTION SITE SWELLING 11 0.0001
390 BURNING SENSATION 10 0.0001
391 BLINDNESS UNILATERAL 2 0.0001
392 MUSCLE SPASMS 26 0.0001
393 PRURITUS 54 0.0001
394 FEAR OF INJECTION 1 0.0001
395 FAECES DISCOLOURED 3 0.0001
396 PRODUCT PRESCRIBING ISSUE 3 0.0001
397 FAECES SOFT 1 0.0001
398 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
399 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
400 BONE PAIN 8 0.0001
401 THERAPY CESSATION 7 0.0001
402 ILLNESS 14 0.0001
403 BLINDNESS TRANSIENT 1 0.0001
404 CHROMATURIA 3 0.0001
405 PAROSMIA 1 0.0001
406 OSTEOPENIA 2 0.0001
407 HEPATOCELLULAR CARCINOMA 1 0.0001
408 DISCOMFORT 8 0.0001
409 ACIDOSIS 1 0.0001
410 PROCEDURAL COMPLICATION 1 0.0001
411 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
412 WEIGHT DECREASED 36 0.0001
413 BASAL CELL CARCINOMA 2 0.0001
414 BRAIN FOG 2 0.0001
415 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
416 DRUG SCREEN POSITIVE 1 0.0001
417 COVID-19 22 0.0001
418 BLOOD DISORDER 1 0.0001
419 BLOOD PRESSURE INCREASED 19 0.0001
420 SENSORY LOSS 1 0.0001
421 HYPERHIDROSIS 16 0.0001
422 POST PROCEDURAL INFECTION 1 0.0001
423 POLYURIA 1 0.0001
424 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 22 0.0001
425 ABNORMAL FAECES 1 0.0001
426 HYPERAESTHESIA 1 0.0001
427 ESCHERICHIA INFECTION 1 0.0001
428 HEART RATE INCREASED 12 0.0001
429 EMBOLISM 1 0.0001
430 LIP SWELLING 4 0.0001
431 HOT FLUSH 9 0.0001
432 ABDOMINAL PAIN LOWER 3 0.0001
433 SKIN PLAQUE 1 0.0001
434 PRODUCT COMPLAINT 3 0.0001
435 VITAMIN D DECREASED 1 0.0001
436 MUSCLE STRAIN 1 0.0001
437 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
438 MUSCULOSKELETAL PAIN 6 0.0001
439 COLD SWEAT 2 0.0001
440 PRODUCT COMMUNICATION ISSUE 1 0.0001
441 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
442 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
443 PRODUCT USE ISSUE 21 0.0001
444 HEAVY MENSTRUAL BLEEDING 1 0.0001
445 GASTROENTERITIS VIRAL 2 0.0001
446 SKIN DISCOLOURATION 5 0.0001
447 CONJUNCTIVITIS 2 0.0001
448 DYSGEUSIA 8 0.0001
449 HEPATIC STEATOSIS 2 0.0001
450 RENAL DISORDER 5 0.0001
451 APPENDICITIS 1 0.0001
452 DEFORMITY 1 0.0001
453 SQUAMOUS CELL CARCINOMA 1 0.0001
454 LEUKAEMIA 1 0.0001
455 FLATULENCE 6 0.0001
456 BLOOD GLUCOSE DECREASED 5 0.0001
457 ATELECTASIS 1 0.0001
458 ERUCTATION 2 0.0001
459 NEEDLE ISSUE 3 0.0001
460 HEPATIC ENZYME INCREASED 7 0.0001
461 KIDNEY INFECTION 2 0.0001
462 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
463 HEPATOMEGALY 1 0.0001
464 SLEEP DISORDER 7 0.0001
465 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
466 ABDOMINAL PAIN 23 0.0001
467 DRUG INEFFECTIVE 130 0.0001
468 TASTE DISORDER 2 0.0001
469 DRUG LEVEL DECREASED 1 0.0001
470 EUPHORIC MOOD 1 0.0001
471 EAR DISCOMFORT 1 0.0001
472 HELICOBACTER INFECTION 1 0.0001
473 INFLUENZA LIKE ILLNESS 8 0.0001
474 GYNAECOMASTIA 3 0.0001
475 HYPERSENSITIVITY 18 0.0001
476 TENDERNESS 1 0.0001
477 DECREASED APPETITE 22 0.0001
478 PALPITATIONS 11 0.0001
479 INSOMNIA 25 0.0001
480 JOINT INJURY 2 0.0001
481 LIVER FUNCTION TEST INCREASED 2 0.0001
482 NIGHT SWEATS 3 0.0001
483 POOR QUALITY SLEEP 2 0.0001
484 BALANCE DISORDER 8 0.0001
485 RASH PRURITIC 5 0.0001
486 NASOPHARYNGITIS 17 0.0001
487 SWELLING FACE 6 0.0001
488 SKIN LACERATION 1 0.0001
489 GASTROINTESTINAL PAIN 1 0.0001
490 ANAPHYLACTIC REACTION 5 0.0001
491 DENTAL CARIES 1 0.0001
492 VIRAL INFECTION 3 0.0001
493 HYPERTENSIVE CRISIS 1 0.0001
494 GAIT INABILITY 3 0.0001
495 INFLUENZA 10 0.0001
496 OCULAR DISCOMFORT 1 0.0001
497 BLISTER 5 0.0001
498 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
499 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
500 CHOLECYSTECTOMY 1 0.0001
501 PROSTATE CANCER 7 0.0001
502 MUSCLE TWITCHING 2 0.0001
503 VASCULITIS 1 0.0001
504 SEXUAL DYSFUNCTION 1 0.0001
505 BLOOD IRON DECREASED 1 0.0001
506 FATIGUE 65 0.0001
507 ABDOMINAL DISCOMFORT 14 0.0001
508 HEPATIC CANCER 2 0.0001
509 ADRENAL INSUFFICIENCY 1 0.0001
510 PRESYNCOPE 2 0.0001
511 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
512 INJECTION SITE EXTRAVASATION 1 0.0001
513 GENERALISED OEDEMA 1 0.0001
514 EYE SWELLING 3 0.0001
515 PAIN 49 0.0001
516 INTRAOCULAR PRESSURE INCREASED 1 0.0001
517 HYPOPHAGIA 2 0.0001
518 SINUSITIS 8 0.0001
519 ROTATOR CUFF SYNDROME 1 0.0001
520 HIATUS HERNIA 1 0.0001
521 DIPLOPIA 2 0.0001
522 ARTHRITIS 6 0.0001
523 URINARY TRACT INFECTION 13 0.0001
524 ORAL CANDIDIASIS 1 0.0001
525 IMMUNE SYSTEM DISORDER 1 0.0001
526 PULMONARY CONGESTION 1 0.0001
527 SARS-COV-2 TEST POSITIVE 1 0.0001
528 DYSMENORRHOEA 1 0.0001
529 ADVERSE REACTION 1 0.0001
530 EAR INFECTION 2 0.0001
531 DEHYDRATION 10 0.0001
532 MALIGNANT MELANOMA 1 0.0001
533 UVEITIS 1 0.0001
534 RASH 32 0.0001
535 IMPAIRED GASTRIC EMPTYING 1 0.0001
536 LUNG NEOPLASM MALIGNANT 3 0.0001
537 CORONARY ARTERY OCCLUSION 1 0.0001
538 PERIPHERAL COLDNESS 1 0.0001
539 VISUAL IMPAIRMENT 9 0.0001
540 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
541 ABNORMAL DREAMS 2 0.0001
542 DIVERTICULITIS 2 0.0001
543 ROAD TRAFFIC ACCIDENT 3 0.0001
544 BLOOD TEST ABNORMAL 1 0.0001
545 SEASONAL ALLERGY 1 0.0001
546 DIZZINESS 35 0.0001
547 PARALYSIS 1 0.0001
548 HYPERSOMNIA 2 0.0001
549 DIARRHOEA 45 0.0001
550 LETHARGY 4 0.0001
551 PRODUCT SUBSTITUTION ISSUE 4 0.0001
552 ERYTHEMA 14 0.0001
553 NASAL CONGESTION 4 0.0001
554 ABDOMINAL PAIN UPPER 14 0.0001
555 PULMONARY MASS 1 0.0001
556 GASTROINTESTINAL DISORDER 6 0.0001
557 FEELING ABNORMAL 16 0.0001
558 BLOOD POTASSIUM DECREASED 2 0.0001
559 TREMOR 11 0.0001
560 PRODUCT QUALITY ISSUE 9 0.0001
561 LYMPHOMA 1 0.0001
562 MUSCULOSKELETAL CHEST PAIN 1 0.0001
563 TENDONITIS 1 0.0001
564 BLOOD CHOLESTEROL INCREASED 3 0.0001
565 CONSTIPATION 14 0.0001
566 MENINGIOMA 1 0.0001
567 BONE DENSITY DECREASED 2 0.0001
568 ULCER 1 0.0001
569 CYSTITIS 2 0.0001
570 SENSORY DISTURBANCE 1 0.0001
571 ATRIAL FIBRILLATION 6 0.0001
572 BLOOD POTASSIUM INCREASED 1 0.0001
573 MALAISE 27 0.0001
574 IMPAIRED HEALING 2 0.0001
575 MULTIPLE FRACTURES 1 0.0001
576 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
577 COAGULOPATHY 1 0.0001
578 URINARY RETENTION 2 0.0001
579 SOMNOLENCE 12 0.0001
580 CELLULITIS 3 0.0001
581 RENAL IMPAIRMENT 5 0.0001
582 CANDIDA INFECTION 1 0.0001
583 CONDITION AGGRAVATED 18 0.0001
584 SCAR 1 0.0001
585 DEVICE DEFECTIVE 1 0.0001
586 OEDEMA PERIPHERAL 7 0.0001
587 MYOCARDIAL INFARCTION 10 0.0001
588 RASH MACULAR 2 0.0001
589 SYRINGE ISSUE 1 0.0001
590 COUGH 16 0.0001
591 GOUT 1 0.0001
592 OEDEMA 3 0.0001
593 OSTEOMYELITIS 1 0.0001
594 RESTLESS LEGS SYNDROME 1 0.0001
595 DYSURIA 2 0.0001
596 ADVERSE EVENT 5 0.0001
597 OROPHARYNGEAL PAIN 5 0.0001
598 ARTHROPATHY 3 0.0001
599 NECK PAIN 3 0.0001
600 BACTERIAL INFECTION 1 0.0001
601 CARDIAC DISORDER 5 0.0001
602 PHOTOPHOBIA 1 0.0001
603 CEREBROVASCULAR ACCIDENT 9 0.0001
604 MUSCULAR WEAKNESS 6 0.0001
605 FOOT FRACTURE 1 0.0001
606 PROTEINURIA 1 0.0001
607 FEELING JITTERY 1 0.0001
608 SLEEP APNOEA SYNDROME 1 0.0001
609 POST PROCEDURAL COMPLICATION 1 0.0001
610 ACUTE RESPIRATORY FAILURE 1 0.0001
611 GLAUCOMA 1 0.0001
612 PRESCRIBED OVERDOSE 1 0.0001
613 EAR PAIN 1 0.0001
614 HAEMORRHOIDS 1 0.0001
615 VISION BLURRED 7 0.0001
616 DYSPEPSIA 5 0.0001
617 BLOOD PRESSURE ABNORMAL 1 0.0001
618 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
619 PRODUCT PHYSICAL ISSUE 1 0.0000
620 HEADACHE 31 0.0000
621 ILL-DEFINED DISORDER 3 0.0000
622 EXTRA DOSE ADMINISTERED 2 0.0000
623 VERTIGO 3 0.0000
624 OSTEOPOROSIS 2 0.0000
625 INJECTION SITE WARMTH 1 0.0000
626 TOOTH LOSS 1 0.0000
627 WITHDRAWAL SYNDROME 2 0.0000
628 KNEE ARTHROPLASTY 1 0.0000
629 OSTEOARTHRITIS 2 0.0000
630 GAIT DISTURBANCE 9 0.0000
631 RETCHING 1 0.0000
632 DEEP VEIN THROMBOSIS 3 0.0000
633 MENTAL DISORDER 2 0.0000
634 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
635 ANXIETY 13 0.0000
636 NAUSEA 36 0.0000
637 DEVICE DIFFICULT TO USE 3 0.0000
638 ASTHENIA 17 0.0000
639 GLOSSODYNIA 1 0.0000
640 SNEEZING 1 0.0000
641 THERAPY NON-RESPONDER 2 0.0000
642 PANCREATITIS ACUTE 1 0.0000
643 HEART RATE IRREGULAR 1 0.0000
644 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
645 PERICARDIAL EFFUSION 1 0.0000
646 PNEUMONIA 14 0.0000
647 CHEST PAIN 8 0.0000
648 CHILLS 5 0.0000
649 MIGRAINE 4 0.0000
650 PRODUCTIVE COUGH 2 0.0000
651 RASH ERYTHEMATOUS 2 0.0000
652 MOBILITY DECREASED 3 0.0000
653 MENTAL IMPAIRMENT 1 0.0000
654 NEURALGIA 1 0.0000
655 UNDERDOSE 3 0.0000
656 ALOPECIA 8 0.0000
657 DEPRESSION 9 0.0000
658 CARDIOVASCULAR DISORDER 1 0.0000
659 FLUSHING 4 0.0000
660 ANAPHYLACTIC SHOCK 1 0.0000
661 SKIN ULCER 1 0.0000
662 NO ADVERSE EVENT 7 0.0000
663 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
664 ANHEDONIA 1 0.0000
665 HYPERTENSION 8 0.0000
666 BLOOD BILIRUBIN INCREASED 1 0.0000
667 LIMB INJURY 1 0.0000
668 RESPIRATORY DISTRESS 1 0.0000
669 MENTAL STATUS CHANGES 1 0.0000
670 MEDICATION ERROR 2 0.0000
671 FEELING COLD 1 0.0000
672 HAEMOPTYSIS 1 0.0000
673 WOUND 1 0.0000
674 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
675 PAIN IN JAW 1 0.0000
676 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
677 LIVER FUNCTION TEST ABNORMAL 1 0.0000
678 INTENTIONAL PRODUCT MISUSE 3 0.0000
679 DYSSTASIA 1 0.0000
680 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
681 DYSPHONIA 2 0.0000
682 ASCITES 1 0.0000
683 ACUTE MYOCARDIAL INFARCTION 1 0.0000
684 LABORATORY TEST ABNORMAL 1 0.0000
685 WHEEZING 2 0.0000
686 CATARACT 2 0.0000
687 RESPIRATORY DISORDER 1 0.0000
688 IRRITABILITY 2 0.0000
689 LACRIMATION INCREASED 1 0.0000
690 THERAPEUTIC RESPONSE DECREASED 2 0.0000
691 EPILEPSY 1 0.0000
692 OVERDOSE 7 0.0000
693 SWOLLEN TONGUE 1 0.0000
694 DYSPHAGIA 3 0.0000
695 LOSS OF CONSCIOUSNESS 4 0.0000
696 HIP FRACTURE 1 0.0000
697 DRUG INTOLERANCE 3 0.0000
698 RHINORRHOEA 2 0.0000
699 AMNESIA 2 0.0000
700 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
701 FALL 10 0.0000
702 SYNCOPE 3 0.0000
703 SKIN DISORDER 1 0.0000
704 HYPOTENSION 6 0.0000
705 TYPE 2 DIABETES MELLITUS 1 0.0000
706 MEMORY IMPAIRMENT 4 0.0000
707 HAEMORRHAGE 3 0.0000
708 INJURY 2 0.0000
709 HYPOXIA 1 0.0000
710 DYSPNOEA 16 0.0000
711 LYMPHADENOPATHY 1 0.0000
712 INFECTION 4 0.0000
713 HYPERGLYCAEMIA 1 0.0000
714 PANIC ATTACK 1 0.0000
715 AGITATION 2 0.0000
716 BRONCHITIS 2 0.0000
717 SEPSIS 3 0.0000
718 HEPATIC FUNCTION ABNORMAL 1 0.0000
719 DEATH 23 0.0000
720 DYSARTHRIA 1 0.0000
721 DYSPNOEA EXERTIONAL 1 0.0000
722 ASTHMA 3 0.0000
723 UNEVALUABLE EVENT 2 0.0000
724 ACNE 2 0.0000
725 CHRONIC KIDNEY DISEASE 2 0.0000
726 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
727 THROMBOSIS 2 0.0000
728 DYSKINESIA 1 0.0000
729 VOMITING 11 0.0000
730 RECTAL HAEMORRHAGE 1 0.0000
731 HYPOACUSIS 1 0.0000
732 OFF LABEL USE 20 0.0000
733 ANGIOEDEMA 1 0.0000
734 TACHYCARDIA 2 0.0000
735 DRY SKIN 3 0.0000
736 THROAT IRRITATION 1 0.0000
737 HYPOKALAEMIA 1 0.0000
738 COGNITIVE DISORDER 1 0.0000
739 ARRHYTHMIA 1 0.0000
740 OCULAR HYPERAEMIA 1 0.0000
741 PULMONARY EMBOLISM 2 0.0000
742 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
743 AGGRESSION 1 0.0000
744 ACUTE KIDNEY INJURY 3 0.0000
745 CHEST DISCOMFORT 2 0.0000
746 INFLAMMATION 1 0.0000
747 NERVOUSNESS 1 0.0000
748 ECZEMA 1 0.0000
749 PANCREATITIS 1 0.0000
750 DRUG INTERACTION 3 0.0000
751 BRADYCARDIA 1 0.0000
752 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
753 PANCYTOPENIA 1 0.0000
754 EYE PAIN 1 0.0000
755 EYE IRRITATION 1 0.0000
756 SEIZURE 2 0.0000
757 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
758 BLADDER CANCER 1 0.0000
759 EMOTIONAL DISTRESS 2 0.0000
760 PLEURAL EFFUSION 1 0.0000
761 BLOOD CREATININE INCREASED 1 0.0000
762 RENAL FAILURE 2 0.0000
763 BLOOD PRESSURE DECREASED 1 0.0000
764 PYREXIA 5 0.0000
765 CARDIAC FAILURE 1 0.0000
766 CARDIAC ARREST 1 0.0000
767 SKIN EXFOLIATION 1 0.0000
768 SUICIDAL IDEATION 1 0.0000
769 ANAEMIA 2 0.0000
770 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
771 RHEUMATOID ARTHRITIS 1 0.0000
772 DISEASE PROGRESSION 1 0.0000
773 PSORIASIS 1 0.0000
774 DRUG DEPENDENCE 1 0.0000